Form 4 for CLPT ClearPoint Neuro, Inc.

Accepted 2026-03-05 00:00:00 ET · period of report 2026-03-03 · accession 0001193125-26-094131 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2026-03-05	2026-03-03	CLPT	STIGALL L. JEREMY	Chief Business Off	M - OptEx	—	+8,856	81.2K	+12%	—
D	2026-03-05	2026-03-03	CLPT	STIGALL L. JEREMY	Chief Business Off	F - Tax	$8.84	-4,506	76.7K	-6%	-$39.8K
D	2026-03-05	2026-03-03	CLPT	STIGALL L. JEREMY	Chief Business Off	M - OptEx	—	-8,856	35.4K	-20%	—

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2026-03-03	M	A	8,856	—	81,212	D	—	—	(F1) Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.
2	Common	Common Stock	2026-03-03	F	D	4,506	$8.84	76,706	D	—	—	(F2) Represents the amount of shares delivered to CLPT to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock.
3	Derivative	Restricted Stock Units	2026-03-03	M	D	8,856	—	35,424	D	— · — to —	8,856 Common Stock	(F1) Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.